Rhenman & Partners Asset Management AB as of Dec. 31, 2021
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | 4.0 | $61M | 120k | 504.43 | |
| Pfizer (PFE) | 3.9 | $58M | 1.0M | 58.40 | |
| Eli Lilly & Co. (LLY) | 3.1 | $47M | 170k | 277.25 | |
| Horizon Therapeutics Pub L SHS | 3.1 | $46M | 425k | 108.26 | |
| Anthem (ELV) | 3.0 | $46M | 98k | 467.15 | |
| Abbvie (ABBV) | 3.0 | $46M | 335k | 135.93 | |
| McKesson Corporation (MCK) | 2.9 | $44M | 177k | 248.90 | |
| Johnson & Johnson (JNJ) | 2.9 | $44M | 253k | 172.31 | |
| CVS Caremark Corporation (CVS) | 2.8 | $43M | 410k | 103.68 | |
| Boston Scientific Corporation (BSX) | 2.6 | $39M | 910k | 42.99 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.5 | $37M | 290k | 128.26 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $37M | 165k | 222.45 | |
| Cigna Corp (CI) | 2.1 | $32M | 140k | 230.75 | |
| Medtronic SHS (MDT) | 2.1 | $31M | 296k | 104.47 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $30M | 175k | 171.03 | |
| Thermo Fisher Scientific (TMO) | 1.9 | $29M | 44k | 665.45 | |
| AmerisourceBergen (COR) | 1.9 | $29M | 218k | 133.77 | |
| Biogen Idec (BIIB) | 1.8 | $28M | 115k | 240.00 | |
| Humana (HUM) | 1.7 | $26M | 55k | 466.27 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $24M | 265k | 89.08 | |
| Merck & Co (MRK) | 1.5 | $23M | 300k | 77.14 | |
| Becton, Dickinson and (BDX) | 1.5 | $23M | 91k | 253.26 | |
| Cooper Cos Com New | 1.5 | $23M | 54k | 424.01 | |
| Mirati Therapeutics | 1.5 | $22M | 150k | 148.23 | |
| Centene Corporation (CNC) | 1.4 | $21M | 255k | 83.99 | |
| Biohaven Pharmaceutical Holding | 1.4 | $21M | 150k | 138.27 | |
| Apellis Pharmaceuticals (APLS) | 1.4 | $21M | 430k | 47.95 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $20M | 390k | 52.13 | |
| Gilead Sciences (GILD) | 1.3 | $20M | 275k | 73.36 | |
| Guardant Health (GH) | 1.3 | $20M | 200k | 100.23 | |
| Seagen | 1.3 | $20M | 127k | 157.19 | |
| Abiomed | 1.3 | $19M | 52k | 362.06 | |
| Xencor (XNCR) | 1.2 | $18M | 450k | 40.74 | |
| Axonics Modulation Technolog (AXNX) | 1.2 | $18M | 315k | 56.22 | |
| Tenet Healthcare Corp Com New (THC) | 1.1 | $17M | 210k | 81.91 | |
| Veeva Sys Cl A Com (VEEV) | 1.0 | $16M | 60k | 260.02 | |
| Privia Health Group (PRVA) | 1.0 | $15M | 580k | 26.50 | |
| Hca Holdings (HCA) | 1.0 | $15M | 59k | 258.10 | |
| Intuitive Surgical Com New (ISRG) | 1.0 | $15M | 40k | 363.30 | |
| Abbott Laboratories (ABT) | 0.9 | $14M | 100k | 141.00 | |
| R1 Rcm | 0.9 | $14M | 550k | 25.20 | |
| Nektar Therapeutics (NKTR) | 0.9 | $13M | 950k | 14.00 | |
| Edwards Lifesciences (EW) | 0.9 | $13M | 100k | 130.68 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $13M | 151k | 84.63 | |
| Danaher Corporation (DHR) | 0.8 | $12M | 36k | 328.47 | |
| Teladoc (TDOC) | 0.8 | $12M | 125k | 94.35 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $12M | 600k | 19.42 | |
| Zimmer Holdings (ZBH) | 0.8 | $12M | 90k | 128.27 | |
| ImmunoGen | 0.7 | $11M | 1.5M | 7.45 | |
| Inspire Med Sys (INSP) | 0.7 | $11M | 46k | 230.24 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.7 | $11M | 750k | 14.22 | |
| Meiragtx Holdings (MGTX) | 0.7 | $11M | 450k | 23.23 | |
| Align Technology (ALGN) | 0.7 | $9.9M | 15k | 662.20 | |
| Health Catalyst (HCAT) | 0.6 | $9.7M | 240k | 40.56 | |
| Novocure Ord Shs (NVCR) | 0.6 | $9.6M | 120k | 79.83 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.6 | $9.5M | 220k | 43.31 | |
| 1life Healthcare | 0.6 | $9.2M | 530k | 17.36 | |
| Silk Road Medical Inc Common (SILK) | 0.6 | $8.7M | 200k | 43.30 | |
| EXACT Sciences Corporation (EXAS) | 0.6 | $8.6M | 110k | 77.89 | |
| Glaukos (GKOS) | 0.5 | $8.0M | 175k | 45.84 | |
| Oak Street Health | 0.5 | $7.7M | 220k | 35.07 | |
| Cytokinetics Com New (CYTK) | 0.5 | $6.8M | 150k | 45.60 | |
| Shockwave Med (SWAV) | 0.4 | $6.1M | 34k | 179.65 | |
| Sangamo Biosciences (SGMO) | 0.4 | $6.0M | 765k | 7.81 | |
| Essa Pharma Com New (EPIX) | 0.4 | $5.9M | 420k | 14.11 | |
| Iveric Bio | 0.4 | $5.8M | 350k | 16.44 | |
| Accolade (ACCD) | 0.4 | $5.5M | 210k | 26.27 | |
| Aerie Pharmaceuticals | 0.4 | $5.4M | 750k | 7.17 | |
| Phreesia (PHR) | 0.3 | $5.2M | 124k | 42.44 | |
| Progyny (PGNY) | 0.3 | $5.2M | 101k | 51.29 | |
| Stereotaxis Com New (STXS) | 0.3 | $5.0M | 800k | 6.22 | |
| Sage Therapeutics (SAGE) | 0.3 | $5.0M | 115k | 43.25 | |
| Esperion Therapeutics (ESPR) | 0.3 | $5.0M | 1.0M | 4.96 | |
| Alkermes SHS (ALKS) | 0.3 | $4.9M | 210k | 23.35 | |
| Macrogenics (MGNX) | 0.3 | $4.9M | 301k | 16.28 | |
| Olema Pharmaceuticals (OLMA) | 0.3 | $4.7M | 500k | 9.40 | |
| Viewray (VRAYQ) | 0.3 | $4.1M | 775k | 5.32 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.3 | $4.1M | 1.5M | 2.68 | |
| Myovant Sciences | 0.3 | $4.0M | 250k | 16.07 | |
| Vocera Communications | 0.3 | $3.8M | 60k | 64.00 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $3.6M | 186k | 19.46 | |
| G1 Therapeutics (GTHX) | 0.2 | $3.4M | 325k | 10.46 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $3.1M | 90k | 34.10 | |
| Annexon (ANNX) | 0.2 | $2.9M | 250k | 11.61 | |
| Fibrogen (FGEN) | 0.2 | $2.8M | 200k | 14.12 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $2.6M | 140k | 18.71 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $2.3M | 75k | 30.55 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.1 | $2.1M | 196k | 10.68 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $1.2M | 300k | 3.94 | |
| Innovage Hldg Corp (INNV) | 0.0 | $741k | 150k | 4.94 | |
| Epizyme | 0.0 | $702k | 265k | 2.65 | |
| Deciphera Pharmaceuticals (DCPH) | 0.0 | $604k | 60k | 10.07 |
